lenvatinib,sunitinib,everolimus,pembrolizumab
merck,pfizer,eisai
['clear trial']
dr thomas hutson presents long-term f/u of #clear trial at #asco23 #kidneycancer. i need some time to digest these surprising findings. will update my thoughts as they evolve. here are my initial impressions: 1/ 
Med onc at UW/SCCA/Fred Hutch focused on melanoma and RCC, interested in patient/caregiver QOL and all things immunotherapy. All opinions are my own.